IJCRR - Vol 06 Issue 24, December, 2014
PREVALENCE OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN HOSPITALIZED PATIENTS
Author: Vineeta Mittal, Fareya Haider
Aims: Study the prevalence of multidrug resistant Ps. aeruginosa in hospitalized patients by antibiotic sensitivity test and detection of MBL producing Ps. aeruginosa by two phenotypic methods.
Methods: Total numbers of 83 samples were taken from patients admitted in wards of different departments. Specimens were inoculated on Mac Conkey agar and sheep blood agar. Identification of isolates was done by colony characteristics and biochemical reactions. These isolates were then subjected to susceptibility testing against various antibiotics by Kirby-Bauer disc diffusion test as per CLSI guidelines. Imipenem resistant isolates were selected for the detection of metallo-beta-lactamases production by two phenotypic methods ie Modified Hodge Test and Imipenem-EDTA combined disc test and confirmed by E test
Results: In this study eleven imipenem resistant isolates were found. Out of which six were found positive for MBL by modified Hodge test, Disc synergy test and MBL E test .These MBL positive isolates were mostly from urine samples.
Conclusion: Clinical microbiology laboratories should use proper phenotypic screening methods in all imipenem resistant isolates. In patients admitted in hospital, there should be careful and conservative use of Carbapenems. Most of MBL producing Ps.aeruginosa were isolated from urine specimen coming from surgery wards, so strict vigilance of catheterized operated patients is needed..
Keywords: Carbapenem resistance, Metallo-beta-lactamase, Pseudomonas aeruginosa
Vineeta Mittal, Fareya Haider. PREVALENCE OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN HOSPITALIZED PATIENTS International Journal of Current Research and Review. Vol 06 Issue 24, December, 48-53
1. Gladstone P, Rajendran P, Brahmadathan KN. Incidence of carbapenem resistant nonfermenting Gram negative bacilli from patients with respiratory infections in the intensive care unit. Indian J Med Microbiol2005; 23: 189-91.
2. Bush K, Jacoby GA, Medeiros A. A functional classification scheme for beta lactamase and its correlation with molecular structure. Antimicrob Agents Chemother1995; 39: 1211-33.
3. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallob-lactamase: the Quiet before the Storm? ClinMicrobiol Rev2005; 18: 306-25.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty second informational supplement. CLSI document2012; M100-S22, 32(3).
5. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-ß-lactamase producing isolates of Pseudomonas spp. and Acinetobacter spp. J ClinMicrobiol2003; 41: 4623-4629.
6. Bonfiglio G, Laksai Y, Franchino L, Amicosante G, Nicoletti G. Mechanisms of b-lactam resistance amongst Pseudomonasaeruginosaisolated in an Italian survey. J AntimicrobChemother1998; 42: 697-702.
7. Shashikala, Kanungo R, Srinivasan S, Devi S. Emerging resistance to carbapenem in hospital acquired Pseudomonas infection: A cause of concern. Indian J Pharmacol2006; 38: 287-8.
8. Navaneeth BV, Sridaran D, Sahay D, Belwadi MR. A preliminary study on metallo beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med. Res2002; 116: 264-267
9. Zavascki AP, Barth AL, Gaspareto PB, Goncalvez AL, Moro AL, Fernandes JF, Goldani LZ. Risk factors for nosocomial infections due to Pseudomonas aeruginosaproducing metallo-betalactamase in two tertiary care teaching hospitals. J AntimicrobChemother2006; 58: 882-885.
10. Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo-beta-lactamase producing Pseudomonasaeruginosain ICU. Indian J Med Res2008; 127: 398-402.
11. Hirakata Y, Izumikawa K, Yamaguchi T, Takemura H, Tanaka H, Yoshida R. Rapid detection and evaluation of clinical characteristics of emerging multi-drug resistant gramnegative rods carrying metallo-ß-lactamase gene blaIMP. Antimicrob Agents Chemother1998; 42: 2006-2011.
12. Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-betalactamase producing Pseudomonas aeruginosa. Indian J MedMicrobiol 2008; 26: 233-237.
13. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-ßlactamase producing clinical isolates of Pseudomonas spp. AndAcinetobacter spp. J ClinMicrobiol2002; 40: 3798- 3801
14. Bashir D, Thokar MA, Fomda BA, Bashir G, Zahoor D, Ahmad S and Toboli AS. Detection of metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosaat a tertiary care hospital in Kashmir. African Journal of Microbiology Research 2011;5(2):164-172
15. Pitout J, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosaproducing metalloßlactamases in a large centralized laboratory. J ClinMicrobiol2005; 43: 3129-3135.
16. Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase producing Pseudomonas aeruginosa. Clin Infect Dis2003; 37: 26-32.
17. Agarwal VA, Dongre SA, Powar RM. Antimicrobial resistance profile of Pseudomonas aeruginosaproducing metallo-betalactamase. Indian J Med Res2006; 124: 588-590.,